Institution
Hackensack Meridian Health
- 26running trials
- 7closed trials
- 3,692publications (OpenAlex)
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
Recruiting
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
Recruiting
Recruiting
Active, not recruiting
Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia
Recruiting
A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
Active, not recruiting
P-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple Myeloma
Recruiting
Combination Therapy for the Treatment of Diffuse Midline Gliomas
Active, not recruiting
A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Study of LAM561 Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid Tumors
Active, not recruiting
Recruiting
Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
Active, not recruiting
Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant Transplant
Active, not recruiting
First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers3 recruiting
- Multiple myeloma2 recruiting
- Stroke2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Atrial fibrillation1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- IgA nephropathy1 recruiting
- Lung cancer1 recruiting
- Lupus (SLE)1 recruiting
- Myelodysplastic syndromes1 recruiting
- Pancreatic cancer1 recruiting
- Prostate cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Terminated
Terminated
Completed
Terminated
Phase 2b Study of GC4711 in Combination With SBRT for Nonmetastatic Pancreatic Cancer
Terminated
Recruiting
Completed
Registry name variants (8)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Hackensack Meridian Health
Hackensack, New Jersey 07601
21 trials
Hackensack Meridian Health
Neptune City, New Jersey 07753
3 trials
Contact: Novartis Pharmaceuticals
Hackensack Meridian Health - JFK Johnson Rehabilitation Institute
Edison, New Jersey 08820
3 trials
NCT07624825Emotional Awareness Therapy Study
Contact: Sarah Enock, BS
Contact: Sarah Enock
NCT05651945Cardiac Rehabilitation of Stroke Survivors (SRP-CROSS)
Contact: Hayk Petrosyan, PhD
Hackensack Meridian Health
Edison, New Jersey 88837
2 trials
Hackensack Meridian Health
Nutley, New Jersey 07110
1 trial
NCT06960993Mosaic Trial for Stem Cell Transplant Recipients
Contact: Heather Derry-Vick, PhD
Hackensack Meridian Health
Paramus, New Jersey 07652
1 trial
Hackensack Meridian Health, Inc
Edison, New Jersey 08837
1 trial
NCT04299191Study of LAM561 Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid Tumors
Contact: Derek Hanson, MD
Hackensack Meridian Health, JFK University Medical
Plainfield, New Jersey 07060
1 trial
Conditions
Diseases this institution publishes on or runs trials for.
- Myelodysplastic syndromes11 works · 1 trial
Institution data: ROR 04p5zd128 (CC0-1.0)Updated 15 Nov 2026